RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
Approved
DIN Number
02518716
Drug Class
Human
Market Date
Aug 25, 2021
Company
HC
laboratoire riva inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518716
AIG Number0352327001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification
ACTIVE INGREDIENTS (3)
EFAVIRENZActive
Strength: 600 MG
Monograph: EFAVIRENZ
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
TENOFOVIR DISOPROXIL FUMARATEActive
Strength: 300 MG
Monograph: TENOFOVIR DISOPROXIL FUMARATE